On Wednesday, Citigroup Inc (NYSE:C)’s shares inclined 1.10% to $52.57.
Citi declared Citi Bike® for Good, a month-long initiative enabling Citi Bike riders to support three of New York City’s most impactful not-for-profit organizations when they ride. Between September 16 and October 16, every Citi Bike ride will support the American Red Cross, No Kid Hungry® and the YMCA of Greater New York. During Citi Bike for Good, hundreds of specially-branded bicycles will hit the streets. Citi will kick off the activation with a base donation of $10,000 for each charity and will follow with up to $40,000 in additional donations to the respective organizations based on ridership during the initiative.
During Citi Bike for Good, any Citi Bike ride – on a specially branded bicycle or a traditional Citi Bike bicycle – will be counted toward the program’s aim of surpassing total riders during the same period in 2014 – 1 million rides. If the aim is met, Citi will contribute an additional $25,000 to each not-for-profit organization. Citi will host additional Pulse Ridership Challenges to encourage overall participation. These challenges will be worth a bonus of $5,000 per organization if the aims are met, resulting in an additional possible $15,000 total donation. The specific ridership aims for the Pulse Ridership Challenges will be declared during the month. The challenges will comprise:
- Super Commuters Challenge:Rides in a work week, September 21 - September 25
- Weekend Warrior Challenge:Rides in a weekend, October 3 and October 4
- Interborough Explorers Challenge:Borough-to-borough rides, October 7 - October 11
Citigroup Inc., a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions worldwide. The company operates through two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG). The GCB segment offers traditional banking services to retail customers through retail banking, commercial banking, Citi-branded cards, and Citi retail services.
Alcatel Lucent SA (ADR) (NYSE:ALU)’s shares gained 1.13% to $3.58.
Alcatel-Lucent (ALU) released figures showing that in the first half of 2015 the number of security threats on mobile net operates have come increasingly from a seemingly unlikely source – personal computers and laptops.
The research also found a noteworthy enhance in the number of ‘spyphone’ apps being detected on both Android and iOS mobile devices.
The Motive® Security Labs H1 2015 Malware Report examines general trends and statistics for malware infections in devices connected through mobile and fixed netoperates. Data is aggregated across fixed and mobile netoperates where Motive Security Guardian malware detection technology is deployed, covering more than 100 million devices.
In the first half of 2015 report, Alcatel-Lucent estimates that 80 percent of malware infections detected on mobile netoperates have been traced to Windows™-based computers and laptops. This finding represents a noteworthy change from 2013 and 2014 when the source of mobile network infections were roughly split 50:50 between Android and Windows™-supported devices.
Alcatel-Lucent provides Internet protocol (IP) and cloud networking, and ultra- broadband access worldwide. The company’s Core Networking segment offers IP routing, carrier Ethernet, network functions virtualization, and software defined networking applications and infrastructure to meet the challenges of network traffic growth while supporting the delivery of cloud-enabled business, mobile, and residential services for service providers, mobile network operators, cable/multiple system operators, transportation, utilities, and large-scale enterprises.
At the end of Wednesday’s trade, SYSCO Corporation (NYSE:SYY)‘s shares surged 0.18% to $39.53.
At its 2015 Investor Day, Sysco Corporation (SYY) senior executives presented a three-year planned business plan designed to improve the customer experience, enhance associate engagement and deliver strong financial results to drive shareholder value over time.
Sysco anticipates to achieve its new operating income and return on invested capital targets by accelerating local case growth, improving gross margins, leveraging its end-to-end supply chain, reducing administrative costs and generating more than $1 billion in free cash flow per year.
Joining DeLaney in presenting the Sysco plan to investors were Tom Bene, executive vice president and president of foodservice operations; Scott Charlton, executive vice president, supply chain; Joel Grade, executive vice president and chief financial officer; and Wayne Shurts, executive vice president and chief technology officer.
Sysco Corporation, through its auxiliaries, markets and distributes a range of food and related products primarily to the foodservice or food-away-from-home industry. It distributes a line of frozen foods, such as meats, seafood, fully prepared entrees, fruits, vegetables, and desserts; a line of canned and dry foods; fresh meats and seafood; dairy products; beverage products; imported specialties; and fresh produce.
Boston Scientific Corporation (NYSE:BSX), ended its Wednesday’s trading session with 0.18% gain, and closed at $17.11.
Boston Scientific (BSX) has received CE Mark for the Vercise™ Primary Cell (PC) Deep Brain Stimulation (DBS) System. The Vercise PC System is intended to provide precise neural targeting to address the varying needs of patients suffering from Parkinson’s disease (PD), primary and secondary dystonia, and essential tremor. The System is a non-rechargeable treatment option that also powers the Vercise DBS Directional Lead, the first commercially accessible eight-contact segmented lead with current steering.
The Vercise platform is the only DBS solution that finely controls the size and shape of stimulation with multiple independent current control technology (MICC). The new Directional Lead with MICC produces multi-directional stimulation which enhances target efficiency. The system comprises unique software solutions with a Clinical Effects Map (CEM) that captures data over time, visually summarizes the progress of individualized patient therapy, and enables physicians to monitor and modify treatment as needed. These novel features allow for programming flexibility, designed to enable better outcomes with fewer side effects.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
